G-CSF is not necessary to maintain over 99% dose–intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis
Title:
G-CSF is not necessary to maintain over 99% dose–intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis
Author:
Evens, Andrew M. Cilley, Jeffrey Ortiz, Taylor Gounder, Mrinal Hou, Nanjiang Rademaker, Alfred Miyata, Sarah Catsaros, Kara Augustyniak, Connie Bennett, Charles L Tallman, Martin S. Variakojis, Daina Winter, Jane N. Gordon, Leo I.